Results 161 to 170 of about 662,606 (363)

Homocitrullinated Peptides Drive Pro‐Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Anti‐homocitrullinated protein/peptide antibodies are specific to rheumatoid arthritis (RA) and predictive of worse prognosis, suggesting a pathogenic role for autoreactivity to homocitrullinated peptides (HomoCitP). However, T cell responses to HomoCitP remain largely unexplored.
Sofya Ulanova   +6 more
wiley   +1 more source

Introduction and roll-out of malaria vaccine in Sierra Leone: early lessons and experiences from the first 8 months of implementation

open access: yesThe Lancet Primary Care
Summary: Sierra Leone became the third country globally to roll-out the malaria vaccine, following Cameroon and Burkina Faso. As part of its comprehensive prevention and control measures against malaria, the Government of Sierra Leone, with the support ...
Desmond M Kangbai, MPhil   +9 more
doaj   +1 more source

General best practice guidelines for immunization, Part two

open access: yes
This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.

core  

Immunization Information System Functional Standards Version 4.2 Resource Guide [PDF]

open access: yes
This document lists primary resources associated with the IIS Functional Standards v 4.1. The resources were created collaboratively and vetted with the immunization information systems (IIS) community unless otherwise noted.

core  

The role of IgM anti‐acetylated protein antibodies and B cells in the origin of anti‐modified protein autoimmunity in rheumatoid arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Rheumatoid arthritis (RA) is characterized by anti‐modified protein antibodies (AMPAs), including anti‐citrullinated (ACPA), anti‐carbamylated (anti‐CarP), and anti‐acetylated (AAPA) protein antibodies. In contrast to other AMPAs, AAPA IgM is found in healthy individuals, raising questions about its role in early immune responses.
Aegli Athanasiadou   +10 more
wiley   +1 more source

On new immunization strategies under random shocks on the term structure of interest rates [PDF]

open access: yes
We introduce new measures of immunization such as exponential duration referring, in particular, to Fong and Vasièek [7], Nawalkha and Chambers [14], Balbás and Ibánez [2], and Balbás et al.
Marek Kaluszka, Alina Kondratiuk-Janyska
core  

Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys. [PDF]

open access: yes, 2004
This facility-based study estimated the costs of providing child immunization services in Dhaka, Bangladesh, from the perspective of healthcare providers.
Fox-Rushby, Julia   +5 more
core  

Immunoinformatics‐Based Design of a Multi‐Epitope Vaccine Targeting a Conserved Copper–Associated Protein in Neisseria gonorrhoeae

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Neisseria gonorrhoeae poses an urgent public health challenge due to rapidly increasing antimicrobial resistance and the absence of an effective vaccine. Targeting conserved bacterial pathways involved in essential physiological processes may provide new opportunities for vaccine antigen discovery.
Sinethemba H. Yakobi   +1 more
wiley   +1 more source

Annual document lists, 1979-1985 / Expanded Programme on Immunization

open access: yes, 1986
Document incorporates documents EPI/GEN/83/9 and EPI/GEN/84/12WHO/EPI/GEN/86/3.
WHO Expanded Programme on Immunization
core  

Targeting Amastigote and Trypomastigote Phases: Multi‐Epitope Vaccine Strategy Against Trypanosoma cruzi

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Effective vaccines against Trypanosoma cruzi, the causative agent of Chagas disease, are urgently needed. Here, we report the design and in silico validation of a novel multiepitope vaccine construct targeting the key surface proteins ASP‐2 and gp82. Using a comprehensive immunoinformatics pipeline, we identified and selected 38 potent T‐cell (
Maria Karolaynne da Silva   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy